BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 34505752)

  • 1. Pityriasis rubra pilaris treatment options: A retrospective case series from a tertiary hospital.
    Ringin S; Baker CS; Foley P; Daniel BS
    Dermatol Ther; 2021 Nov; 34(6):e15128. PubMed ID: 34505752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical improvement of pityriasis rubra pilaris with efalizumab in a pediatric patient.
    Gómez M; Ruelas ME; Welsh O; Arcaute HD; Ocampo-Candiani J
    J Drugs Dermatol; 2007 Mar; 6(3):337-9. PubMed ID: 17373198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythrodermic pityriasis rubra pilaris treatment: Two case reports and literature review.
    Camela E; Miano C; Di Caterino P; Lo Presti M; De Fata Salvatores G; Fabbrocini G; Megna M
    Dermatol Ther; 2020 Nov; 33(6):e14223. PubMed ID: 32820849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of a child's pityriasis rubra pilaris (PRP) with ustekinumab and acitretin.
    Katharina M; Sylvia S; Matthias B; Ulrich M; Martin L
    Pediatr Dermatol; 2022 Jul; 39(4):659-661. PubMed ID: 35859269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infliximab monotherapy as first-line treatment for adult-onset pityriasis rubra pilaris: case report and review of the literature on biologic therapy.
    Müller H; Gattringer C; Zelger B; Höpfl R; Eisendle K
    J Am Acad Dermatol; 2008 Nov; 59(5 Suppl):S65-70. PubMed ID: 19119128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secukinumab for the treatment of adult-onset pityriasis rubra pilaris: a single-arm clinical trial with transcriptomic analysis.
    Boudreaux BW; Pincelli TP; Bhullar PK; Patel MH; Brumfiel CM; Li X; Heckman MG; Pittelkow MR; Mangold AR; Sluzevich JC
    Br J Dermatol; 2022 Nov; 187(5):650-658. PubMed ID: 35701384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Refractory pityriasis rubra pilaris treated with etanercept, adalimumab, or ustekinumab: A retrospective investigation.
    Maloney NJ; Hisaw LD; Worswick S
    Dermatol Ther; 2017 Nov; 30(6):. PubMed ID: 29034547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pityriasis rubra pilaris. Case reports and review of the literature].
    Artik S; Megahed M; Ruzicka T
    Hautarzt; 2003 Sep; 54(9):858-63. PubMed ID: 12955264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of pityriasis rubra pilaris type I: a systematic review.
    Engelmann C; Elsner P; Miguel D
    Eur J Dermatol; 2019 Oct; 29(5):524-537. PubMed ID: 31789274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pityriasis rubra pilaris, type 1.
    Booth AV; Ma L
    Dermatol Online J; 2005 Dec; 11(4):9. PubMed ID: 16403381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pityriasis rubra pilaris: clinicopathological study of 32 cases from Lebanon.
    Marrouche N; Kurban M; Kibbi AG; Abbas O
    Int J Dermatol; 2014 Apr; 53(4):434-9. PubMed ID: 24783259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methotrexate treatment in a case of juvenile pityriasis rubra pilaris.
    Boyd AH; Polcari IC
    Pediatr Dermatol; 2018 Jan; 35(1):e62-e63. PubMed ID: 29044698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of refractory adult-onset pityriasis rubra pilaris with TNF-alpha antagonists: a case series.
    Garcovich S; Di Giampetruzzi AR; Antonelli G; Garcovich A; Didona B
    J Eur Acad Dermatol Venereol; 2010 Aug; 24(8):881-4. PubMed ID: 20002243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of pityriasis rubra pilaris: a case series of 28 patients.
    Kromer C; Lippert U; Schön MP; Mössner R
    Eur J Dermatol; 2020 Oct; 30(5):569-579. PubMed ID: 33021474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pityriasis rubra pilaris].
    Artik S; Kuhn A; Neumann NJ; Ruzicka T; Megahed M
    Hautarzt; 2004 Oct; 55(10):980-3. PubMed ID: 15365642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biologics for Treatment of Pityriasis Rubra Pilaris: A Literature Review.
    Chandy RJ; Chokshi A; Tan I; Feldman SR
    J Cutan Med Surg; 2024; 28(3):269-275. PubMed ID: 38549359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late onset pityriasis rubra pilaris type IV treated with low-dose acitretin.
    Mota F; Carvalho S; Sanches M; Selores M
    Acta Dermatovenerol Alp Pannonica Adriat; 2016; 25(1):15-7. PubMed ID: 27014774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ustekinumab treatment of pityriasis rubra pilaris: A report of five cases.
    Napolitano M; Lembo L; Fania L; Abeni D; Didona D; Didona B
    J Dermatol; 2018 Feb; 45(2):202-206. PubMed ID: 29080273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pityriasis rubra pilaris.
    White KL
    Dermatol Online J; 2003 Oct; 9(4):6. PubMed ID: 14594579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Juvenile pityriasis rubra pilaris: report of 28 cases in Taiwan.
    Yang CC; Shih IH; Lin WL; Yu YS; Chiu HC; Huang PH; Cheng YW; Lee JY; Chen W
    J Am Acad Dermatol; 2008 Dec; 59(6):943-8. PubMed ID: 18819727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.